サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1529847

分子イメージングの市場規模、シェア、動向分析レポート：モダリティ別、用途別、最終用途別、地域別、セグメント別予測、2024年～2030年

Molecular Imaging Market Size, Share & Trends Analysis Report By Modality (SPECT, NMR), By Application (Oncology, Cardiology), By End-use (Hospitals, Diagnostic Imaging Centers), By Region, And Segment Forecasts, 2024 - 2030

出版日
ページ情報
英文 220 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.96円
分子イメージングの市場規模、シェア、動向分析レポート：モダリティ別、用途別、最終用途別、地域別、セグメント別予測、2024年～2030年
出版日: 2024年07月24日
発行: Grand View Research
ページ情報: 英文 220 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

分子イメージング市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の分子イメージング市場規模は2030年までに114億4,000万米ドルに達し、2024年から2030年までのCAGRは4.52％で成長すると予測されています。

市場成長の主な要因は、技術の進歩、がんの有病率の増加、研究開発への投資の増加などです。例えば、国際がん研究機関によると、2022年には世界で約19,976,499人の新規がん患者と9,743,832人のがん関連死が報告されています。

がん、心血管疾患、神経疾患などの慢性疾患の有病率の増加により、効果的な診断ツールが必要とされており、分子イメージング市場の成長に大きく貢献すると期待されています。PET（Positron Emission Tomography）、SPECT（Single Photon Emission Computed Tomography）、NMR（Nuclear Magnetic Resonance）スペクトロメーターなどの分子イメージング装置は、この点で特に効率的です。これらの先端技術は、様々な疾病に関連する代謝プロセス、分子活動、構造変化に関する詳細な洞察を提供します。これらによってヘルスケア専門家は、腫瘍、心機能、神経学的異常の範囲や特徴を高い精度と正確さで可視化し、評価することができます。

さらに、分子イメージングによって、たとえ不顕性の段階であっても疾患の早期発見が容易になり、タイムリーな介入と個別化された治療計画が可能になります。このプロアクティブなアプローチは、患者の予後を改善するだけでなく、進行した病期や合併症に関連するヘルスケアコストを削減します。

M&A、製品上市、規制当局の承認、提携、共同研究、研究開発（R&D）活動など、主要市場プレーヤーが実施する戦略的イニシアチブは、分子イメージング市場の成長を促進する上で重要な役割を果たしています。例えば、2024年1月、Bruker Corporationはオハイオ州立大学のNational Gateway超高磁場NMRセンターに最先端の1.2ギガヘルツ（GHz）NMRシステムの設置に成功しました。このGHz級NMRシステムは、核磁気共鳴（NMR）分光法の大きな進歩を象徴するもので、生命科学や材料科学の研究に革命をもたらすことを目指しています。

分子イメージング市場レポートハイライト

  • モダリティ別では、単一光子放射型コンピュータ断層撮影（SPECT）セグメントが2023年に43.8%のシェアを獲得して優位を占める。
  • 核磁気共鳴（NMR）スペクトロメーターセグメントは、2024年から2030年にかけて最も速いCAGRで成長すると予測されています。
  • 用途別では、腫瘍学セグメントが2023年に33.7％のシェアを獲得して最大市場シェアを占めました。
  • 最終用途別では、病院セグメントが2023年に市場の大半のシェアを占めました。
  • 画像診断センターセグメントは、2024年から2030年にかけて最も速い速度で成長すると予測されています。
  • 北米が2023年に41.7％のシェアを占めました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 分子イメージング市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場牽引要因分析
    • 市場抑制要因分析
  • 分子イメージング市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 分子イメージング市場：モダリティ別推定・動向分析

  • セグメントダッシュボード
  • 世界の分子イメージング市場のモダリティ別変動分析
  • 世界の分子イメージング市場規模と動向分析、モダリティ別、2018～2030年
  • 分子超音波イメージング
  • 陽電子放出断層撮影（PET）
  • 単一光子放出コンピュータ断層撮影（SPECT）
  • 核磁気共鳴（NMR）分光計
  • その他のモダリティ

第5章 分子イメージング市場：用途別推定・動向分析

  • セグメントダッシュボード
  • 世界の分子イメージング市場の用途別変動分析
  • 世界の分子イメージング市場規模と動向分析、用途別、2018～2030年
  • 心臓血管
  • 神経学
  • 腫瘍学
  • 呼吸器
  • 胃腸

第6章 分子イメージング市場：最終用途別推定・動向分析

  • セグメントダッシュボード
  • 世界の分子イメージング市場の最終用途別変動分析
  • 世界の分子イメージング市場規模と動向分析、最終用途別、2018～2030年
  • 病院
  • 画像診断センター
  • 調査機関

第7章 分子イメージング市場：用途、最終用途別の地域別推定・動向分析

  • 地域別市場シェア分析、2023年および2030年
  • 地域別市場ダッシュボード
  • 世界の地域市場スナップショット
  • 市場規模と予測動向分析、2018年から2030年
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第8章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
  • 主要企業の市場シェア分析、2023年
  • 企業のポジション分析
  • 企業分類（新興企業、イノベーター、リーダー）
  • 企業プロファイル
    • Bruker
    • GE HealthCare
    • Siemens Healthineers
    • Koninklijke Philips NV
    • Canon Medical Systems Corporation
    • Mediso, Cubresa Inc.
    • Shimadzu Corporation
    • United Imaging Healthcare Co
    • Positron Corporation
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America molecular imaging market, By country, 2018 - 2030 (USD Million)
  • Table 4 North America molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 5 North America molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 6 North America molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 7 U.S. molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 8 U.S. molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 9 U.S. molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 10 Canada molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 11 Canada molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 12 Canada molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 13 Mexico molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 14 Mexico molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 15 Mexico molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 16 Europe molecular imaging market, By country, 2018 - 2030 (USD Million)
  • Table 17 Europe molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 18 Europe molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 19 Europe molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 20 UK molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 21 UK molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 22 UK molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 23 Germany molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 24 Germany molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 25 Germany molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 26 France molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 27 France molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 28 France molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 29 Italy molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 30 Italy molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 31 Italy molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 32 Denmark molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 33 Denmark molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 34 Denmark molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 35 Sweden molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 36 Sweden molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 37 Sweden molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 38 Norway molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 39 Norway molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 40 Norway molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific molecular imaging market, By country, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 45 Japan molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 46 Japan molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 47 Japan molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 48 China molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 49 China molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 50 China molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 51 India molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 52 India molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 53 India molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 54 Australia molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 55 Australia molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 56 Australia molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 57 South Korea molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 58 South Korea molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 59 South Korea molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 60 Thailand molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 61 Thailand molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 62 Thailand molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 63 Latin America molecular imaging market, By Country, 2018 - 2030 (USD Million)
  • Table 64 Latin America molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 65 Latin America molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 66 Latin America molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 67 Brazil molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 68 Brazil molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 69 Brazil molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 70 Argentina molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 71 Argentina molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 72 Argentina molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 73 Middle East & Africa molecular imaging market, By country, 2018 - 2030 (USD Million)
  • Table 74 Middle East & Africa molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 75 Middle East & Africa molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 76 Middle East & Africa molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 77 South Africa molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 78 South Africa molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 79 South Africa molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 80 Saudi Arabia molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 83 UAE molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 84 UAE molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 85 UAE molecular imaging market, By end-use, 2018 - 2030 (USD Million)
  • Table 86 Kuwait molecular imaging market, By modality, 2018 - 2030 (USD Million)
  • Table 87 Kuwait molecular imaging market, By application, 2018 - 2030 (USD Million)
  • Table 88 Kuwait molecular imaging market, By end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Molecular Imaging market: market outlook
  • Fig. 14 Parent market outlook
  • Fig. 15 Related/ancillary market outlook
  • Fig. 16 Penetration and growth prospect mapping
  • Fig. 17 Industry value chain analysis
  • Fig. 18 Molecular imaging market driver impact
  • Fig. 19 Molecular imaging market restraint impact
  • Fig. 20 Molecular imaging market: Modality movement analysis
  • Fig. 21 Molecular imaging market: Modality outlook and key takeaways
  • Fig. 22 Molecular ultrasound imaging market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Positron emission tomography (PET) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Single photon emission computed tomography (SPECT) market estimates and forecast, 2018-2030 (USD Million)
  • Fig. 25 Nuclear magnetic resonance (NMR) spectrometer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Other modalities market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Molecular imaging market: Application movement analysis
  • Fig. 28 Molecular imaging market: Application outlook and key takeaways
  • Fig. 29 Cardiovascular market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Neurology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Respiratory market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Gastrointestinal market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Molecular imaging market: End use movement analysis
  • Fig. 35 Molecular imaging market: End use outlook and key takeaways
  • Fig. 36 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Diagnostic imaging centers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Research institutes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Global molecular imaging market: Regional movement analysis
  • Fig. 40 Global molecular imaging market: Regional outlook and key takeaways
  • Fig. 41 North America
  • Fig. 42 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 U.S.
  • Fig. 44 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Canada
  • Fig. 46 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Mexico
  • Fig. 48 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Europe
  • Fig. 50 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 UK
  • Fig. 52 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Germany
  • Fig. 54 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 France
  • Fig. 56 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Italy
  • Fig. 58 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Spain
  • Fig. 60 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Denmark
  • Fig. 62 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Sweden
  • Fig. 64 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Norway
  • Fig. 66 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Asia Pacific
  • Fig. 68 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 China
  • Fig. 70 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Japan
  • Fig. 72 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 India
  • Fig. 77 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Thailand
  • Fig. 76 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 South Korea
  • Fig. 78 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Australia
  • Fig. 80 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Latin America
  • Fig. 82 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Brazil
  • Fig. 84 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Mexico
  • Fig. 86 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Argentina
  • Fig. 88 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Middle East and Africa
  • Fig. 90 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 South Africa
  • Fig. 92 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Saudi Arabia
  • Fig. 94 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 UAE
  • Fig. 96 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Kuwait
  • Fig. 98 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Market share of key market players- Molecular imaging market
目次
Product Code: GVR-4-68040-374-6

Molecular Imaging Market Growth & Trends:

The global molecular imaging market size is anticipated to reach USD 11.44 billion by 2030, growing at a CAGR of 4.52% from 2024 to 2030, according to a new report by Grand View Research, Inc. The major factors contributing to market growth include technological advancements, increase in prevalence of cancer, and rising investment in R&D. For instance, according to the International Agency for Research on Cancer, approximately 19,976,499 new cancer cases and 9,743,832 cancer-related deaths were reported globally in 2022.

The growing prevalence of chronic disorders such as cancer, cardiovascular diseases, and neurological conditions necessitates effective diagnostic tools, which are expected to significantly contribute to the growth of the molecular imaging market. Molecular imaging devices such as PET (Positron Emission Tomography), SPECT (Single Photon Emission Computed Tomography), and Nuclear Magnetic Resonance (NMR) Spectrometer are particularly efficient in this regard. These advanced technologies provide detailed insights into the metabolic processes, molecular activities, and structural changes associated with various diseases. They enable healthcare professionals to visualize and assess the extent and characteristics of tumors, cardiac function, and neurological abnormalities with high precision and accuracy.

Moreover, molecular imaging facilitates early detection of diseases, even at subclinical stages, allowing for timely intervention and personalized treatment planning. This proactive approach not only improves patient outcomes but also reduces healthcare costs associated with advanced disease stages and complications.

Strategic initiatives undertaken by major market players, including mergers and acquisitions, product launches, regulatory approvals, partnerships, collaborations, and research and development (R&D) activities, play a crucial role in driving the growth of the molecular imaging market. For instance, in January 2024, Bruker Corporation successfully installed a state-of-the-art 1.2 Gigahertz (GHz) NMR system at The Ohio State University's National Gateway Ultrahigh Field NMR Center. This GHz-class NMR system represents a significant advancement in nuclear magnetic resonance (NMR) spectroscopy, aiming to revolutionize research in life sciences and materials science.

Molecular Imaging Market Report Highlights:

  • Based on the modality segment, the Single Photon Emission Computed Tomography (SPECT) segment dominated by capturing a share of 43.8% in 2023
  • The Nuclear Magnetic Resonance (NMR) Spectrometer segment is anticipated to grow at the fastest CAGR from 2024 to 2030
  • Based on application, the oncology segment held the largest market share in the application segment by capturing a share of 33.7% in 2023.
  • Based on end use, the hospital segment held a majority share of the market in 2023.
  • Diagnostic imaging centers segment is expected to grow at the fastest rate from 2024 to 2030
  • North America dominated the market with a share of 41.7% in 2023.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Modality
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Modality outlook
    • 2.2.2. Application outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Molecular Imaging Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of cancer and other chronic diseases
      • 3.2.1.2. Technological advancements
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High Cost of Equipment and Treatment
  • 3.3. Molecular Imaging Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Molecular Imaging Market: Modality Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Molecular Imaging Modality Market Movement Analysis
  • 4.3. Global Molecular Imaging Market Size & Trend Analysis, by Modality, 2018 to 2030 (USD Million)
  • 4.4. Molecular Ultrasound Imaging
    • 4.4.1. Molecular ultrasound imaging market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Positron Emission Tomography (PET)
    • 4.5.1. Positron emission tomography (PET) market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Single Photon Emission Computed Tomography (SPECT)
    • 4.6.1. Single photon emission computed tomography (SPECT) market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Nuclear Magnetic Resonance (NMR) Spectrometer
    • 4.7.1. Nuclear Magnetic resonance (NMR) spectrometer market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Other Modalities
    • 4.8.1. Other modalities market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Molecular Imaging Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Molecular Imaging Application Market Movement Analysis
  • 5.3. Global Molecular Imaging Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Cardiovascular
    • 5.4.1. Cardiovascular market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Neurology
    • 5.5.1. Neurology market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Oncology
    • 5.6.1. Oncology market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Respiratory
    • 5.7.1. Respiratory market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Gastrointestinal
    • 5.8.1. Gastrointestinal market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Molecular Imaging Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Molecular Imaging End Use Market Movement Analysis
  • 6.3. Global Molecular Imaging Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Diagnostic Imaging Centers
    • 6.5.1. Diagnostic imaging centers market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Research institutes
    • 6.6.1. Research institutes market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Molecular Imaging Market: Regional Estimates & Trend Analysis By Application, End Use

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Competitive scenario
      • 7.5.1.3. Regulatory framework
      • 7.5.1.4. Reimbursement structure
      • 7.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory framework
      • 7.5.2.4. Reimbursement structure
      • 7.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Regulatory framework
      • 7.5.3.4. Reimbursement structure
      • 7.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Competitive scenario
      • 7.6.1.3. Regulatory framework
      • 7.6.1.4. Reimbursement structure
      • 7.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Reimbursement structure
      • 7.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. Reimbursement structure
      • 7.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Regulatory framework
      • 7.6.4.4. Reimbursement structure
      • 7.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. Regulatory framework
      • 7.6.5.4. Reimbursement structure
      • 7.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. Regulatory framework
      • 7.6.6.4. Reimbursement structure
      • 7.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Competitive scenario
      • 7.6.7.3. Regulatory framework
      • 7.6.7.4. Reimbursement structure
      • 7.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Competitive scenario
      • 7.6.8.3. Regulatory framework
      • 7.6.8.4. Reimbursement structure
      • 7.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Competitive scenario
      • 7.7.1.3. Regulatory framework
      • 7.7.1.4. Reimbursement structure
      • 7.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Reimbursement structure
      • 7.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Reimbursement structure
      • 7.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Competitive scenario
      • 7.7.4.3. Regulatory framework
      • 7.7.4.4. Reimbursement structure
      • 7.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Competitive scenario
      • 7.7.5.3. Regulatory framework
      • 7.7.5.4. Reimbursement structure
      • 7.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Competitive scenario
      • 7.7.6.3. Regulatory framework
      • 7.7.6.4. Reimbursement structure
      • 7.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Competitive scenario
      • 7.8.1.3. Regulatory framework
      • 7.8.1.4. Reimbursement structure
      • 7.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Regulatory framework
      • 7.8.2.4. Reimbursement structure
      • 7.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Competitive scenario
      • 7.9.1.3. Regulatory framework
      • 7.9.1.4. Reimbursement structure
      • 7.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Competitive scenario
      • 7.9.2.3. Regulatory framework
      • 7.9.2.4. Reimbursement structure
      • 7.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Competitive scenario
      • 7.9.3.3. Regulatory framework
      • 7.9.3.4. Reimbursement structure
      • 7.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Competitive scenario
      • 7.9.4.3. Regulatory framework
      • 7.9.4.4. Reimbursement structure
      • 7.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Key company market share analysis, 2023
  • 8.4. Company Position Analysis
  • 8.5. Company Categorization (Emerging Players, Innovators and Leaders
  • 8.6. Company Profiles
    • 8.6.1. Bruker
      • 8.6.1.1. Company overview
      • 8.6.1.2. Financial performance
      • 8.6.1.3. Product benchmarking
      • 8.6.1.4. Strategic initiatives
    • 8.6.2. GE HealthCare
      • 8.6.2.1. Company overview
      • 8.6.2.2. Financial performance
      • 8.6.2.3. Product benchmarking
      • 8.6.2.4. Strategic initiatives
    • 8.6.3. Siemens Healthineers
      • 8.6.3.1. Company overview
      • 8.6.3.2. Financial performance
      • 8.6.3.3. Product benchmarking
      • 8.6.3.4. Strategic initiatives
    • 8.6.4. Koninklijke Philips N.V.
      • 8.6.4.1. Company overview
      • 8.6.4.2. Financial performance
      • 8.6.4.3. Product benchmarking
      • 8.6.4.4. Strategic initiatives
    • 8.6.5. Canon Medical Systems Corporation
      • 8.6.5.1. Company overview
      • 8.6.5.2. Financial performance
      • 8.6.5.3. Product benchmarking
      • 8.6.5.4. Strategic initiatives
    • 8.6.6. Mediso, Cubresa Inc.
      • 8.6.6.1. Company overview
      • 8.6.6.2. Financial performance
      • 8.6.6.3. Product benchmarking
      • 8.6.6.4. Strategic initiatives
    • 8.6.7. Shimadzu Corporation
      • 8.6.7.1. Company overview
      • 8.6.7.2. Financial performance
      • 8.6.7.3. Product benchmarking
      • 8.6.7.4. Strategic initiatives
    • 8.6.8. United Imaging Healthcare Co
      • 8.6.8.1. Company overview
      • 8.6.8.2. Financial performance
      • 8.6.8.3. Product benchmarking
      • 8.6.8.4. Strategic initiatives
    • 8.6.9. Positron Corporation
      • 8.6.9.1. Company overview
      • 8.6.9.2. Financial performance
      • 8.6.9.3. Product benchmarking
      • 8.6.9.4. Strategic initiatives